Eliot Vichinsky Honoured with ASH Lifetime Achievement Award in Hematology – TIF
Thalassaemia International Federation (TIF) posted on LinkedIn:
“The Thalassaemia International Federation (TIF) proudly congratulates Dr. Eliot Vichinsky on receiving the Wallace H. Coulter Award for Lifetime Achievement in Hematology from the American Society of Hematology (ASH).
This distinguished honour recognises a career that has profoundly advanced the field of Haemoglobin Disorders.
For over 40 years, Dr. Vichinsky has combined groundbreaking research with a steadfast commitment to better diagnosis, treatment and lifelong support for people with Thalassaemia and Sickle Cell Disease. His work has helped shape clinical practice, screening programmes and public-health policy, with lasting benefits for patients worldwide.
A clinician, scientist, advocate and mentor, Dr. Vichinsky has consistently placed the needs and rights of patients at the centre of progress.
TIF warmly thanks Dr. Vichinsky for his immense and enduring contribution to our community.
This recognition could not be more deserved.”
Stay updated with Hemostasis Today.
-
Jul 7, 2026, 16:21Hannah Omunakwe: When Blood Becomes the Limiting Treatment in Sickle Cell Disease
-
Jul 7, 2026, 15:54Barbara Lovrencic: Giving the ITP Patient Voice a Stronger Evidence Base
-
Jul 7, 2026, 15:45Maria Cherska: Can Cardiovascular Prevention Become Truly Personalized If We Ignore Ethnicity?
-
Jul 7, 2026, 15:42Julie Makani: The London Patient – A Milestone in HIV Cure
-
Jul 7, 2026, 15:39July Issue is Now Live – The Lancet Haematology
-
Jul 7, 2026, 15:33Flora Peyvandi: Immune-Mediated Hepatitis After Gene Therapy
-
Jul 7, 2026, 15:31Edward Lee Carter: Understanding Ketorolac Dosing When More Is Not Always Better
-
Jul 7, 2026, 15:18Vicky Probert: A Lifelong Commitment to Saving Lives Through Blood Donation
-
Jul 7, 2026, 14:47Andre W. Bourgoyne: Optimizing Surgical Outcomes Through Anemia Management